Shares of Dr Reddy's Laboratories extended their gains to the second straight day, up as much as 2.4 per cent to Rs 4,748 on the BSE on Thursday. The stock had risen 4.4 per cent in the last trading session after the firm and Russia's sovereign wealth fund, Russian Direct Investment Fund (RDIF), agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India.
Upon regulatory approval in India, RDIF shall supply to Dr. Reddy's 100 million doses of the vaccine, Dr Reddys said in a release on Wednesday. The Sputnik V vaccine, which is based on